D-Index & Metrics Best Publications

John P.H. Wilding

University of Liverpool
United Kingdom

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 84 Citations 32,530 461 World Ranking 9861 National Ranking 929

Overview

What is he best known for?

The fields of study John P.H. Wilding is best known for:

Diabetes mellitus
Obesity
Energy homeostasis

Internal medicine connects with themes related to Dosing in his study. He combines topics linked to Internal medicine with his work on Dosing. John P.H. Wilding applies his multidisciplinary studies on Pathology and Gastroenterology in his research. Gastroenterology and Pathology are two areas of study in which John P.H. Wilding engages in interdisciplinary work. Many of his studies involve connections with topics such as Tolerability and Alternative medicine. His work on Tolerability is being expanded to include thematically relevant topics such as Adverse effect. He performs integrative study on Adverse effect and Alternative medicine in his works. His study ties his expertise on Ingestion together with the subject of Endocrinology. John P.H. Wilding combines topics linked to Endocrinology with his work on Ingestion.

His most cited work include:

Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin (375 citations)
Hypothalamic orexin expression: modulation by blood glucose and feeding. (296 citations)
A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects (197 citations)

What are the main themes of his work throughout his whole career to date

John P.H. Wilding conducted interdisciplinary study in his works that combined Internal medicine and Surgery. John P.H. Wilding merges Surgery with Internal medicine in his study. John P.H. Wilding regularly links together related areas like Insulin in his Endocrinology studies. John P.H. Wilding connects Insulin with Insulin resistance in his research. His Insulin resistance study frequently links to adjacent areas such as Glucose homeostasis. His study deals with a combination of Obesity and Leptin. While working on this project, he studies both Leptin and Obesity. Diabetes mellitus and Blood pressure are two areas of study in which John P.H. Wilding engages in interdisciplinary research. He undertakes multidisciplinary studies into Blood pressure and Diabetes mellitus in his work.

John P.H. Wilding most often published in these fields:

Internal medicine (86.96%)
Endocrinology (69.57%)
Obesity (43.48%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A role for glucagon-like peptide-1 in the central regulation of feeding

M. D. Turton;D. O'Shea;I. Gunn;S. A. Beak.
Nature (1996)

2247 Citations

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

Thomas A Zelniker;Stephen D Wiviott;Itamar Raz;Kyungah Im.
The Lancet (2019)

2150 Citations

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

Xavier Pi-Sunyer;Arne Astrup;Ken Fujioka;Frank Greenway.
The New England Journal of Medicine (2015)

1403 Citations

Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome

Steven R Coughlin;Lynn Mawdsley;Julie A Mugarza;Peter M A Calverley.
European Heart Journal (2004)

1079 Citations

Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin

Jan Bolinder;Östen Ljunggren;Joel Kullberg;Lars Johansson;Lars Johansson.
The Journal of Clinical Endocrinology and Metabolism (2012)

880 Citations

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).

Mikhail Kosiborod;Matthew A. Cavender;Alex Z. Fu;John P. Wilding.
Circulation (2017)

811 Citations

Food fails to suppress ghrelin levels in obese humans.

P. J. English;M. A. Ghatei;I. A. Malik;S. R. Bloom.
The Journal of Clinical Endocrinology and Metabolism (2002)

745 Citations

Management of obesity

George A Bray;Gema Frühbeck;Donna H Ryan;John P H Wilding.
The Lancet (2016)

717 Citations

Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation.

G.A. Bray;K.K. Kim;J.P.H. Wilding.
Obesity Reviews (2017)

690 Citations

Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis

Jay S. Skyler;George L. Bakris;Ezio Bonifacio;Tamara Darsow.
Diabetes (2017)

609 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for John P.H. Wilding